BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Pricing Of Offering Of Inveresk Research (Incorporating CTBR) (IRGI) Common Stock


10/19/2005 5:10:39 PM

CARY, N.C., April 1 /PRNewswire-FirstCall/ -- Inveresk Research Group, Inc. announced today that its principal stockholder yesterday agreed to sell 5,000,000 shares of Inveresk Research common stock at an initial price to the public of $26.75 per share. The offering is comprised entirely of shares being offered by such principal stockholder. The underwriter for the offering is Goldman, Sachs & Co.

This press release does not constitute an offer of the securities described herein. A registration statement relating to the securities has been previously declared effective by the Securities and Exchange Commission. The offering is being made solely by means of a prospectus supplement and the accompanying prospectus, copies of which may be obtained from Goldman Sachs & Co., 85 Broad Street, New York, NY 10004, Attention: Prospectus Department.

Inveresk is a leading provider of drug development services to companies in the pharmaceutical and biotechnology industries. The company is based in Cary, North Carolina with facilities in Edinburgh, Scotland and Montreal, Canada.

Inveresk Research Group, Inc.

CONTACT: Matt Dallas of Financial Dynamics, +1-212-850-5627,mdallas@fd-us.com, for Inveresk Research Group, Inc.



Read at Reuters
Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES